Northpointe Bancshares Stock (NYSE:NPB)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$15.95

52W Range

$11.43 - $18.86

50D Avg

$17.40

200D Avg

$15.08

Market Cap

$542.27M

Avg Vol (3M)

$155.68K

Beta

0.04

Div Yield

$0.10 (0.48%)

NPB Company Profile


Northpointe Bancshares, Inc. operates as the bank holding company for Northpointe Bank provides various banking products and services in the United States. It operates through two segments: Mortgage Purchase Program and Retail Banking. The company offers digital deposit banking, such as noninterest-bearing accounts, savings, money-market demand accounts, and certificates of deposits; personal and business banking; and health saving accounts; home loans; mortgage purchase program; residential mortgage lending; and custodial deposit services. Northpointe Bancshares, Inc. was incorporated in 1998 and is headquartered in Grand Rapids, Michigan.

Show More

Industry

Banks - Regional

Sector

Financial Services

Exchange

NYSE

ADR

-

Country

US

Employees

491

IPO Date

Feb 18, 2025

Website

NPB Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Supply Of Investigational Products$10.83M$28.10M$47.91M
Licensing and Collaboration$16.81M$-249.66M$40.12M

Fiscal year ends in Dec 24 | Currency in USD

NPB Financial Summary


Dec 24Dec 23Dec 22
Revenue$185.77M$196.29M$257.56M
Operating Income---
Net Income$55.16M$33.76M$23.24M
EBITDA---
Basic EPS-$0.70$0.40
Diluted EPS-$0.70$0.40

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q3 25Oct 22, 25 | 10:00 AM

Peer Comparison


TickerCompany
CCCCC4 Therapeutics, Inc.
BNRBurning Rock Biotech Limited
ALXOALX Oncology Holdings Inc.
ERASErasca, Inc.
ZLABZai Lab Limited
LEGNLegend Biotech Corporation
CGEMCullinan Therapeutics, Inc.